---
figid: PMC9685729__archdischild-2021-322858f02
pmcid: PMC9685729
image_filename: archdischild-2021-322858f02.jpg
figure_link: /pmc/articles/PMC9685729/figure/F2/
number: Figure 2
figure_title: ''
caption: 'The RASâ€“MAPK signalling pathway showing mutations that may lead to diseases
  such as Noonan syndrome (reproduced with permission from Zenker, 2020). Some of
  the pathway components exist in multiple isoforms (eg, RAS: KRAS, HRAS, NRAS, RRAS;
  RAF: RAF1, BRAF; SOS: SOS1, SOS2, etc). aAlso known as Noonan syndrome with multiple
  lentigines. CFC, cardiofaciocutaneous; MAPK, mitogen-activated protein kinase; P,
  proline; RTK, receptor tyrosine kinase enzyme; Ub, ubiquitin.'
article_title: 'Noonan syndrome: improving recognition and diagnosis.'
citation: Martin Zenker, et al. Arch Dis Child. 2022 Dec;107(12):1073-1078.
year: '2022'

doi: 10.1136/archdischild-2021-322858
journal_title: Archives of Disease in Childhood
journal_nlm_ta: Arch Dis Child
publisher_name: BMJ Publishing Group

keywords:
- endocrinology
- genetics
- syndrome

---
